Estrella Immunopharma, Inc.

TradeUP Acquisition Corp (Nasdaq: UPTD) was a blank-check company that completed its initial public offering in 2021. Targeting the biopharmaceutical and immunotherapy sector, UPTD announced a definitive business combination with Estrella Immunopharma, Inc. in October 2022. Estrella is a clinical-stage company focused on immunotherapy assets and drug development. The transaction has since closed, making UPTD one of the completed SPAC deals from the post-2020 merger wave that brought numerous life-sciences targets to public markets via blank-check vehicles. For complete deal terms, SEC filing history, and post-merger performance data on UPTD and thousands of other SPAC transactions, sign up for full access at SpacDesk.

SPAC Counterparty (1)